Literature DB >> 17177965

Interferon-beta and adhesion molecules (E-selectin and s-intracellular adhesion molecule-1) are detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll-like receptor 3 signalling.

M T Lee1, L C Hooper, L Kump, K Hayashi, R Nussenblatt, J J Hooks, B Detrick.   

Abstract

Retinal vasculitis is a major component of ocular inflammation that plays a role in retinal tissue damage in patients with idiopathic uveitis and Behçet's disease. Here we show that type 1 interferons (IFN alpha/beta) were not detected in sera from normal individuals but were identified in up to 46% of the sera from retinal vasculitis patients. The predominant form of IFN observed was IFN-beta, which was detected in 39% of Behçet's disease patients and 47% of idiopathic uveitis patients. Seven patients whose sera contained IFN-beta were monitored prospectively. IFN-beta was shown to be present for 6-12 months in all seven of the sera samples tested. Furthermore, the adhesion molecule profile identified in this study was strikingly different when Behçet's and uveitis patient sera were compared to sera from normal controls. Sera from Behçet's disease patients contained significantly elevated levels of the soluble adhesion molecules, sE-selectin and s-intracellular adhesion molecule-1 (sICAM-1), whereas sera from patients with idiopathic uveitis contained significantly increased sE-selectin. In vitro studies evaluating the cell source of these cytokines revealed that polyriboinosinic polyribocytidylic acid (poly I:C) activated retinal vascular endothelial cells produce sE-selectin, sICAM-1 and IFN-beta. Production of these molecules was inhibited by pretreatment with anti-Toll-like receptor 3 (TLR-3) antibody. In conclusion, IFN-beta, sE-selectin and sICAM-1 are elevated in patients with retinal vasculitis and are induced in retinal vascular endothelial cells in vitro by activating the innate immune system through TLR-3. Further analysis of innate immune signalling may prove to be a novel target for future studies on pathogenic mechanisms and therapeutic approaches in retinal vasculitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17177965      PMCID: PMC1810441          DOI: 10.1111/j.1365-2249.2006.03253.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Selectin adhesion molecules in Behçet's disease.

Authors:  E Haznedaroglu; Y Karaaslan; Y Büyükaşik; A Koşar; O Ozcebe; b C Haznedaroglu; E Kirazli; S V Dündar
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

2.  Levels of circulating intercellular adhesion molecule-1 in patients with Behçet's disease.

Authors:  Kenan Saglam; M Ilker Yilmaz; Ayse Saglam; Mete Ulgey; Fatih Bulucu; Yavuz Baykal
Journal:  Rheumatol Int       Date:  2002-01       Impact factor: 2.631

3.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

4.  Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.

Authors:  Misako Matsumoto; Satomi Kikkawa; Masayoshi Kohase; Kensuke Miyake; Tsukasa Seya
Journal:  Biochem Biophys Res Commun       Date:  2002-05-24       Impact factor: 3.575

Review 5.  Pattern recognition receptors: doubling up for the innate immune response.

Authors:  Siamon Gordon
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

Review 6.  Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier.

Authors:  John Greenwood; Sandrine Etienne-Manneville; Peter Adamson; Pierre-Olivier Couraud
Journal:  Vascul Pharmacol       Date:  2002-06       Impact factor: 5.773

7.  Serum E-selectin and beta 2-microglobulin levels in Behçet's disease.

Authors:  A Karakuzu; A Aktaş; F Akçay
Journal:  J Int Med Res       Date:  2002 Jan-Feb       Impact factor: 1.671

8.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 10.  Interferons, interferon-like cytokines, and their receptors.

Authors:  Sidney Pestka; Christopher D Krause; Mark R Walter
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

View more
  14 in total

Review 1.  Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome.

Authors:  M T Keogan
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

Review 2.  The role of Toll-like receptors in retinal ischemic diseases.

Authors:  Wen-Qin Xu; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

Review 3.  Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune responses.

Authors:  Christopher B Pattillo; Kai Fang; Justin Terracciano; Christopher G Kevil
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

Review 4.  Adhesion molecules: a way to understand lupus.

Authors:  Karolina Nowak; Olga Gumkowska-Sroka; Przemysław Kotyla
Journal:  Reumatologia       Date:  2022-05-18

5.  Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes.

Authors:  Guomin Jiang; Yan Ke; Deming Sun; Yali Wang; Henry J Kaplan; Hui Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

6.  T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins.

Authors:  Elise P Salerno; Walter C Olson; Chantel McSkimming; Sofia Shea; Craig L Slingluff
Journal:  Int J Cancer       Date:  2014-02-01       Impact factor: 7.396

Review 7.  Role of the retinal vascular endothelial cell in ocular disease.

Authors:  Arpita S Bharadwaj; Binoy Appukuttan; Phillip A Wilmarth; Yuzhen Pan; Andrew J Stempel; Timothy J Chipps; Eric E Benedetti; David O Zamora; Dongseok Choi; Larry L David; Justine R Smith
Journal:  Prog Retin Eye Res       Date:  2012-09-11       Impact factor: 21.198

8.  Three Japanese cases of intraocular inflammation after intravitreal brolucizumab injections in one clinic.

Authors:  Taiichi Hikichi
Journal:  Jpn J Ophthalmol       Date:  2021-02-05       Impact factor: 2.447

9.  Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients.

Authors:  Barbara Detrick; Sapna Gangaputra; Doreen N Palsgrove; Christopher D Heaney; John J Hooks; H Nida Sen
Journal:  J Neuroimmunol       Date:  2017-12-29       Impact factor: 3.478

10.  Suitability of endogenous reference genes for gene expression studies with human intraocular endothelial cells.

Authors:  Ruoxin Wei; Elizabeth Anne Stewart; Winfried M Amoaku
Journal:  BMC Res Notes       Date:  2013-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.